Dimeo 1999.
| Study characteristics | ||
| Methods | Study design: quasi‐randomized controlled trial Number randomized: 62; 29 to the exercise group and 33 to the control group Study start and stop dates: not reported Length of intervention: length of hospitalization Length of follow‐up: to end of the intervention |
|
| Participants | Type cancer, n: various
Time since cancer diagnosis: not reported Time in active treatment: not reported Inclusion criteria:
Eligibility criteria related to interest or ability, or both, to exercise:
Exclusion criteria:
Gender, n:
Current age, mean (SD, range) years:
Age at cancer diagnosis: not reported Ethnicity/race: not reported Education level: not reported SES: not reported Employment status: not reported Comorbidities: not reported Past exercise history: not reported On hormone therapy: not reported BMI, mean (SD, range):
|
|
| Interventions | 29 participants assigned to the exercise intervention, including:
Type exercise (aerobic/anaerobic): aerobic Intensity of the experimental exercise intervention: participants "biked" for 1 minute with an intensity sufficient to reach a HR equivalent to at least 50% of the cardiac reserve, calculated as 220 ‐ age ‐ resting HR Frequency: daily Duration of individual sessions: 30 minutes Duration of exercise program: length of hospitalization Total number of exercise sessions: varied Format: individual Facility: facility Professionally supervised and instructed by study personnel Adherence: 82% (SD, 16%) of the hospitalization days 33 participants assigned to control group, including:
Contamination of control group: not reported |
|
| Outcomes | No primary outcome was identified. QoL outcomes included:
Outcomes were measured at baseline and discharge from hospital (~ 3 months):
Subgroup analysis: none reported Adverse events: not reported |
|
| Notes | Country: Germany Funding: Nenad Keul Foundation, Freiburg, and Daimler‐Benz AG |
|
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | High risk | Quasi‐randomized |
| Allocation concealment (selection bias) | Unclear risk | Whether the treatment assignment was concealed from study personnel and participants was not described |
| Blinding of participants and personnel (performance bias) All outcomes | High risk | Owing to the nature of the intervention, it was not possible to conceal allocation to the intervention from the participants |
| Blinding of outcome assessment (detection bias) All outcomes | High risk | The outcome assessor was blinded to the study allocation |
| Incomplete outcome data (attrition bias) All outcomes | High risk | Analyses were conducted on an ITT basis; However, the treatment of missing data was not described. There was substantial attrition from the trial, especially in the intervention arm |
| Selective reporting (reporting bias) | Low risk | There appears to be no selective reporting of outcomes |
| Other bias | Low risk | The trial appears to be free of other problems that could put it at a high risk of bias |